1. Home
  2. NDAQ vs EW Comparison

NDAQ vs EW Comparison

Compare NDAQ & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDAQ
  • EW
  • Stock Information
  • Founded
  • NDAQ 1971
  • EW 1958
  • Country
  • NDAQ United States
  • EW United States
  • Employees
  • NDAQ N/A
  • EW N/A
  • Industry
  • NDAQ Investment Bankers/Brokers/Service
  • EW Industrial Specialties
  • Sector
  • NDAQ Finance
  • EW Health Care
  • Exchange
  • NDAQ Nasdaq
  • EW Nasdaq
  • Market Cap
  • NDAQ 49.8B
  • EW 45.5B
  • IPO Year
  • NDAQ 2002
  • EW 2000
  • Fundamental
  • Price
  • NDAQ $87.21
  • EW $86.32
  • Analyst Decision
  • NDAQ Buy
  • EW Buy
  • Analyst Count
  • NDAQ 15
  • EW 19
  • Target Price
  • NDAQ $100.29
  • EW $92.35
  • AVG Volume (30 Days)
  • NDAQ 2.8M
  • EW 5.2M
  • Earning Date
  • NDAQ 10-21-2025
  • EW 10-30-2025
  • Dividend Yield
  • NDAQ 1.24%
  • EW N/A
  • EPS Growth
  • NDAQ 66.50
  • EW N/A
  • EPS
  • NDAQ 2.80
  • EW 2.33
  • Revenue
  • NDAQ $8,168,000,000.00
  • EW $5,883,800,000.00
  • Revenue This Year
  • NDAQ N/A
  • EW $13.96
  • Revenue Next Year
  • NDAQ $7.43
  • EW $9.81
  • P/E Ratio
  • NDAQ $31.10
  • EW $37.75
  • Revenue Growth
  • NDAQ 16.40
  • EW 10.60
  • 52 Week Low
  • NDAQ $64.84
  • EW $65.31
  • 52 Week High
  • NDAQ $97.63
  • EW $87.21
  • Technical
  • Relative Strength Index (RSI)
  • NDAQ 46.32
  • EW 74.11
  • Support Level
  • NDAQ $85.04
  • EW $82.01
  • Resistance Level
  • NDAQ $89.19
  • EW $87.21
  • Average True Range (ATR)
  • NDAQ 1.32
  • EW 2.28
  • MACD
  • NDAQ 0.22
  • EW 0.39
  • Stochastic Oscillator
  • NDAQ 48.48
  • EW 87.76

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: